Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis

被引:1
作者
Tang, Qin [1 ]
Zhang, Haojie [2 ]
Tang, Rong [3 ,4 ]
机构
[1] Jingmen Ctr Hosp, Dept Obstet & Gynecol, Jingmen, Peoples R China
[2] Jingmen Ctr Hosp, Dept Operating Room, Jingmen, Peoples R China
[3] Jingmen Ctr Hosp, Dept Pathol, Jingmen, Peoples R China
[4] Jingmen Ctr Hosp, Dept Pathol, Jingmen 448000, Hubei, Peoples R China
关键词
gene set enrichment analysis; immunotype; ovarian cancer; western blotting; WGCNA; CELL; IMMUNOTHERAPY; CCR5;
D O I
10.1097/MD.0000000000035246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune classification of ovarian cancer (OV) becomes more and more influential for its immunotherapy. However, current studies had few immune subtypes of OV. It is urgent to explore the immune subtypes and deeper hub immune-related genes (IRGs) of OV for follow-up treatment. A total number of 379 OV samples were obtained from UCSC online website. Single sample gene set enrichment analysis of 29 immune gene sets was used for identifying immune subtypes of OV and gene set variation analysis were used for exploring the hallmarks and Kyoto Encyclopedia of Genes and Genomes pathways of immune types. Two immunity subtypes (Immunity_H and Immunity_L) were identified by single sample gene set enrichment analysis. The OV patients in Immunity_H group had longer overall survival compared with those in Immunity_L group. The Immunity_H had higher stromal score, immune score and estimate score and the tumor purity had the adverse tendency. Besides, the gene set variation analysis enrichment results showed positive relationship between improved immunoreaction and pathways correlated to classical signaling pathway (PI3K/AKT/MTOR, P53, TNFA/NFkB signaling pathways) and immune responses (T/B cell receptor signaling pathways and primary immunodeficiency). Furthermore, 4 hub IRGs (CCR5, IL10RA, ITGAL and PTPRC) were jointly dug by weighted gene co-expression network construction and Cytoscape. Our team also explored the mutations of 4 hub IRGs and PTPRC showed nearly 7% amplification. Besides, 8 immune-checkpoint genes had higher expression in Immuity_H group compared with Immuity_L group, except CD276. The correlation between PD-1/PD-L1 and 4 hub IRGs were explored and gene set enrichment analysis were conducted to explore the underlying mechanisms of PTPRC in OV. Finally, western-blotting showed PTPRC could regulate immune checkpoint PD-L1 expression via JAK-STAT signaling pathway. In a word, 2 immune subtypes and 4 hub IRGs of OV were identified by multiple analysis.
引用
收藏
页数:10
相关论文
共 44 条
[21]   Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer [J].
Liu, Xiaojun ;
Gao, Jinghai ;
Wang, Jing ;
Chu, Jing ;
You, Jiahao ;
Jin, Zhijun .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (05) :547-559
[22]   Functional analysis of bovine interleukin-10 receptor alpha in response to Mycobacterium avium subsp. paratuberculosis lysate using CRISPR/Cas9 [J].
Mallikarjunappa, Sanjay ;
Shandilya, Umesh K. ;
Sharma, Ankita ;
Lamers, Kristen ;
Bissonnette, Nathalie ;
Karrow, Niel A. ;
Meade, Kieran G. .
BMC GENETICS, 2020, 21 (01)
[23]   Ovarian Cancer Immunotherapy and Personalized Medicine [J].
Morand, Susan ;
Devanaboyina, Monika ;
Staats, Hannah ;
Stanbery, Laura ;
Nemunaitis, John .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
[24]   29 immune-related genes pairs signature predict the prognosis of cervical cancer patients [J].
Nie, Han ;
Bu, Fanqin ;
Xu, Jiasheng ;
Li, Taoshen ;
Huang, Jun .
SCIENTIFIC REPORTS, 2020, 10 (01)
[25]   Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization [J].
Ning, Ning ;
Zhan, Ting ;
Zhang, Yujuan ;
Chen, Qian ;
Feng, Fengzhi ;
Yang, Zhuo ;
Liu, Zhongjuan ;
Xu, Danfei ;
Wang, Fei ;
Guo, Ye ;
Xing, Jia ;
Guan, Yuanyuan ;
Cui, Wei .
CLINICA CHIMICA ACTA, 2014, 433 :69-75
[26]   Cytoscape Automation: empowering workflow-based network analysis [J].
Otasek, David ;
Morris, John H. ;
Boucas, Jorge ;
Pico, Alexander R. ;
Demchak, Barry .
GENOME BIOLOGY, 2019, 20 (01)
[27]   IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma [J].
Prokoph, Nina ;
Probst, Nicola A. ;
Lee, Liam C. ;
Monahan, Jack M. ;
Matthews, Jamie D. ;
Liang, Huan-Chang ;
Bahnsen, Klaas ;
Montes-Mojarro, Ivonne A. ;
Karaca-Atabay, Elif ;
Sharma, Geeta G. ;
Malik, Vikas ;
Larose, Hugo ;
Forde, Sorcha D. ;
Ducray, Stephen P. ;
Lobello, Cosimo ;
Wang, Qi ;
Luan, Shi-Lu ;
Pospisilova, Sarka ;
Gambacorti-Passerini, Carlo ;
Burke, G. A. Amos ;
Pervez, Shahid ;
Attarbaschi, Andishe ;
Janikova, Andrea ;
Pacquement, Helene ;
Landman-Parker, Judith ;
Lambilliotte, Anne ;
Schleiermacher, Gudrun ;
Klapper, Wolfram ;
Jauch, Ralf ;
Woessmann, Wilhelm ;
Vassal, Gilles ;
Kenner, Lukas ;
Merkel, Olaf ;
Mologni, Luca ;
Chiarle, Roberto ;
Brugieres, Laurence ;
Geoerger, Birgit ;
Barbieri, Isaia ;
Turner, Suzanne D. .
BLOOD, 2020, 136 (14) :1657-1669
[28]  
Raychaudhuri S, 2000, Pac Symp Biocomput, P455
[29]   Cancer immunotherapy using checkpoint blockade [J].
Ribas, Antoni ;
Wolchok, Jedd D. .
SCIENCE, 2018, 359 (6382) :1350-+
[30]   New perspectives in ovarian cancer treatment [J].
Schmid, Bernd C. ;
Oehler, Martin K. .
MATURITAS, 2014, 77 (02) :128-136